Tokyo Relife Clinic-linked Goda Lab wins XPRIZE Healthspan milestone award

Goda Lab, with Tokyo Relife Clinic participating through its endowed chair in cellular senescence control, was named one of 10 Milestone 2 Awardees in XPRIZE Healthspan on Sept. 25, 2026. The selection moves the team into clinical research aimed at showing age-related function restoration in adults 50 to 90 and positions it for the competition’s final testing phase in 2030.

Why it matters: - XPRIZE Healthspan is pushing therapies aimed at restoring age-related declines in muscle, cognitive and immune function in adults ages 50 to 90. - The competition’s target is a 10-year restoration, with a goal of 20 years, which could expand healthy lifespan if validated in humans. - Goda Lab’s selection gives Tokyo Relife Clinic a visible role in one of the field’s highest-profile longevity contests.

What happened: - Tokyo Relife Clinic announced that Goda Lab was selected as one of 10 Milestone 2 Awardees in XPRIZE Healthspan on Sept. 25, 2026. - Yoshiaki Furuyama, Tokyo Relife Clinic CEO, participates in Goda Lab through the Endowed Chair of Cellular Senescence Control. - The award recognizes teams advancing therapeutics designed to reverse age-related declines in muscle, cognition and immunity.

The details: - XPRIZE Healthspan is a global, seven-year competition. - The competition seeks therapeutics that can restore age-related declines by at least 10 years within a one-year treatment period, with an ambitious 20-year target. - Goda Lab plans to begin clinical research to demonstrate 10-plus years of restoration in humans. - The team is aiming for the competition’s final testing phase in 2030. - Tokyo Relife Clinic is based in Ginza, Tokyo, and describes itself as a regenerative medicine clinic focused on longevity and healthy lifespan extension. - The clinic provides autologous adipose-derived stem cell therapy, NK cell therapy, autologous cultured fibroblast therapy, PRP therapy, exosome treatments and stem cell conditioned media therapies. - Tokyo Relife Clinic also operates an in-house Cell Processing Center for cell culture and processing. - The clinic says its model integrates clinical care, cell culture, quality control, testing and research.

Between the lines: - The award suggests Goda Lab’s work is moving from research positioning into a more formal validation track. - Tokyo Relife Clinic is using the recognition to reinforce its longevity and anti-aging credentials. - The clinic’s participation through an endowed chair links a private medical practice to a large international research effort, which may help bridge laboratory work and clinical application.

What's next: - Goda Lab will move ahead with clinical research tied to the Milestone 2 selection. - The team will need to show measurable evidence that its approach can restore age-related function in the target population. - XPRIZE Healthspan’s later-stage competition milestones will determine whether the work advances toward final testing in 2030.

The bottom line: - Goda Lab’s milestone win puts Tokyo Relife Clinic-linked research on a global stage focused on one of medicine’s biggest goals: extending healthy human lifespan.